v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 28, 2026
Jun. 29, 2025
Cash flows from operating activities:    
Net income $ 114,670 $ 652,352
Adjustments to reconcile net income to cash provided by operating activities:    
Depreciation and amortization 241,787 218,022
Asset impairment 22,263 846
Loss on early extinguishment of debt recognized as a component of interest expense 17,569 1,419
Stock-based compensation 11,211 14,185
Deferred income tax benefit (5,691) (19,493)
Loan cost amortization 2,689 2,491
Loss on property disposals 2,604 1,990
Accretion of discount related to Senior Notes 1,125 1,211
Gain on equity method investments 0 (3)
Changes in operating assets and liabilities:    
Trade accounts and other receivables 239,435 (74,961)
Inventories (7,604) (105,692)
Prepaid expenses and other current assets (17,457) (17,434)
Accounts payable, accrued expenses and other current liabilities (127,640) (34,570)
Income taxes (6,688) 8,048
Long-term pension and other postretirement obligations 1,259 (1,469)
Other operating assets and liabilities (17,686) (24,839)
Cash provided by operating activities 471,846 622,103
Cash flows from investing activities:    
Acquisitions of property, plant and equipment (465,189) (259,283)
Proceeds from property disposals 10,375 2,912
Business acquisitions (3,073) 0
Cash used in investing activities (457,887) (256,371)
Cash flows from financing activities:    
Payments on revolving line of credit, long-term borrowings and finance lease obligations (313,312) (90,654)
Proceeds from revolving line of credit and long-term borrowings 73,667 0
Payment on early extinguishment of debt (14,548) (2,120)
Payments for dividend 0 (1,495,497)
Cash used in financing activities (254,193) (1,588,271)
Effect of exchange rate changes on cash and cash equivalents (1,697) 37,700
Decrease in cash, cash equivalents, restricted cash and restricted cash equivalents (241,931) (1,184,839)
Cash, cash equivalents, restricted cash and restricted cash equivalents, beginning of period 640,235 2,043,158
Cash, cash equivalents, restricted cash and restricted cash equivalents, end of period $ 398,304 $ 858,319